Form 4: EcoR1 Capital Sells Shares in Prothena Corp Public Ltd Co

EcoR1 Capital, a 10% owner of Prothena Corp Public Ltd Co, reports selling a significant number of ordinary shares over three days in May 2025.

Summary

• EcoR1 Capital, LLC, along with Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P., filed a Form 4 detailing changes in beneficial ownership of Prothena Corp Public Ltd Co shares.
• The transactions involved the sale of ordinary shares on May 2, 2025, May 5, 2025, and May 6, 2025.
• On May 2, 2025, 3,317,938 shares were sold at a weighted average price of $8.3621, with prices ranging from $8.2715 to $9.1789.
• On May 5, 2025, 977,693 shares were sold at a weighted average price of $8.1111, with prices ranging from $8.1097 to $8.1972.
• On May 6, 2025, 1,984,053 shares were sold at a weighted average price of $7.6433, with prices ranging from $7.4637 to $8.5939.
• These sales were executed by Qualified Fund, with EcoR1 acting as the investment advisor and Mr. Nodelman as the manager.
• After these transactions, Qualified Fund held 4,973,891 shares of Prothena's ordinary shares.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the large sale of shares by a major shareholder, which could indicate a lack of confidence or a change in investment strategy.

Negatives

• EcoR1 Capital, a significant shareholder, reduced its stake in Prothena through a series of sales.

Risks

• Continued selling pressure from major shareholders like EcoR1 could negatively impact the stock price.
• The reasons behind EcoR1's decision to reduce its holdings are not disclosed, creating uncertainty.

Industry Context

Form 4 filings are standard disclosures for significant shareholders, providing transparency into their trading activities. Large sales by major holders can sometimes create short-term market volatility.

Stakeholder Impact

• Shareholders may experience short-term price volatility due to the large volume of shares being sold.
• The sales could potentially impact investor confidence in the company.

Key Dates

Keywords

EcoR1 Capital, Prothena Corp, Share Sale, Beneficial Ownership, Form 4, Oleg Nodelman, Qualified Fund